Healthcare Reform Plan
Repeal and replace the $1.6 Trillion taxpayers will spend in federal financing for the exchange premium subsidies, the exchange cost-sharing subsidies, and the funding of the ACA’s Medicaid expansion.
Provide states with a fixed allotment of federal funding. The funding would be based on current state ACA funding and would be gradually rebalanced based on each state’s number of low-income residents, bringing greater equity between the states. The states would adhere to the following guidelines in using their allotments:
- Low income: At least half of a state’s grant funding would be used to provide coverage for low-income populations.
- Private coverage: At least half of a state’s grant funding would be used to support the people’s purchase of private coverage.
- Risk Mitigation: State grant funds could be used to offset the costs of individuals with expensive medical conditions through reinsurance programs or other, similar mechanisms.
- Mental Health Coverage: State grant funds can also be applied as a stop-gap to supplement traditional health plans that offer zero coverage for mental health screenings and treatment.
- Premium support: Individuals who are subsidized by a state grant program, and individuals currently on Medicaid and Children’s
Health Insurance Program (CHIP), would be able to direct their share of funding to the private coverage of their choosing.
- Pro-life protections: By making the grant program an amendment to the existing federal CHIP statute, the current pro-life protections that prohibit taxpayer funding of abortion in CHIP would also apply to the new grant program.
- Optional use: States could also incentivize insurers to offer discounts to individuals who maintain continuous coverage, or to young adults in general, who have been fleeing the market altogether.
Step 3: Extend new regulatory flexibility to States
Requires the repeal of certain costly and constrictive federal regulations, returning state regulatory authority over such matters bringing about more affordable options by:
- The Repeal of the federal single-risk-pool requirement. The ACA requires that in the individual and small-group markets, insurers must set their rates based on the cost of all of their customers in each of those market segments—as opposed to basing rates on the claims cost of the different groups of customers purchasing different plan designs. This federal restriction prevents variation on product price. Repealing this requirement would enable states to target more assistance directly to those with expensive medical conditions while reducing the cost of coverage for other enrollees, so that fewer of them would need subsidies to afford a plan.
- The Repeal of federal essential health-benefit requirements. The ACA requires insurance plans in the individual and small-group market to cover the 10 categories of federal benefits. This federal requirement pre-empted previous state benefit requirements and in most states increased the cost of coverage. Analysis found that this federal requirement has increased premiums between 5 percent and 11 percent, depending on the state.
- The Repeal of the federal medical-loss-ratio requirement. The ACA sets the minimum share of premium income that an insurer must spend on claims costs. This federal requirement perversely discourages insurers from spending money to limit claim payments. It also creates a barrier to new insurers entering the market and to existing insurers expanding into new markets, because it does not account for the higher administrative costs associated with the initial years of such expansions.
- The Repeal of the federal age-rating limitation.
- The ACA limits age variation of premiums for adults to a maximum ratio of three-to-one. Meaning, for the same plan, an insurer is not permitted to charge a 64-year-old a rate that is more than three times the rate for a 19-year-old. Analysis has found that this federal requirement lowered premiums by 10 percent to 15 percent for those between 50 and 64 years of age, but increased premiums for younger adults by about one-third.
- Eliminate Taxation of Self-Paid and Self-Insured medical expenses and premiums.
- In order for all Americans to be created equal concerning medical expenses all Americans should be able to subtract medical expenses from gross income before calculating taxable income.
- Implementation of a comprehensive public pricing structure for consumers.
- Currently there are no laws mandating the publication of pricing for services among health system providers. A full transparent and publicly published pricing structure will give consumers more power to choose their best and most affordable options which will allow for more free market competition driving overall costs down.
- Codify former Executive Orders under the Trump Administration to lower prescription drug prices.
- End a shadowy system of kickbacks by middlemen that lurks behind the high out-of-pocket costs many Americans face at the pharmacy counter. Under this action, American seniors will directly receive these kickbacks as discounts in Medicare Part D. In 2018, these Part D discounts totaled more than $30 billion, representing an average discount of 26 to 30 percent.
- Require federally qualified health centers who purchase insulins and epinephrine in the 340B program to pass the savings from discounted drug prices directly on to medically underserved patients. This will increase access to life-saving insulin and epinephrine for the patients who face especially high costs among the 28 million patients who visit FQHCs every year, over six million of whom are uninsured.
- Finalize a rule allowing states to develop safe importation plans for certain prescription drugs.
- Authorize the re-importation of insulin products made in the United States if the Secretary finds re-importation is required for emergency medical care pursuant to section 801(d) of the Food, Drug, and Cosmetic Act.
- Create a pathway for safe personal importation through the use of individual waivers to purchase drugs at lower cost from pre-authorized U.S. pharmacies.
- Take action to ensure that the Medicare program and seniors pay no more for the most costly Medicare Part B drugs than any economically comparable OECD country, ending foreign countries’ free loading off the backs of American taxpayers and pharmaceutical investments.